Preethi Sundaram - 06 Jul 2021 Form 3 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Product Devel. Officer
Signature
/s/ Preethi Sundaram
Issuer symbol
CPRX
Transactions as of
06 Jul 2021
Net transactions value
$0
Form type
3
Filing time
13 Jul 2021, 16:44:31 UTC
Next filing
30 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CPRX Options to purchase Common Stock 06 Jul 2021 Common Stock 300,000 $5.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options will vest in four equal tranches on July 6, 2022, 2023, 2024 and 2025.